These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 27100376)

  • 1. A case study of community-based distribution and use of Misoprostol and Chlorhexidine in Sokoto State, Nigeria.
    Cannon M; Charyeva Z; Oguntunde O; Sambisa W; Shoretire K; Orobaton N
    Glob Public Health; 2017 Dec; 12(12):1553-1567. PubMed ID: 27100376
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Implementing at-scale, community-based distribution of misoprostol tablets to mothers in the third stage of labor for the prevention of postpartum haemorrhage in Sokoto State, Nigeria: Early results and lessons learned.
    Orobaton N; Abdulazeez J; Abegunde D; Shoretire K; Maishanu A; Ikoro N; Fapohunda B; Balami W; Beal K; Ganiyu A; Gwamzhi R; Austin A
    PLoS One; 2017; 12(2):e0170739. PubMed ID: 28234894
    [TBL] [Abstract][Full Text] [Related]  

  • 3. "My job is to get pregnant women to the hospital": a qualitative study of the role of traditional birth attendants in the distribution of misoprostol to prevent post-partum haemorrhage in two provinces in Mozambique.
    Hobday K; Hulme J; Homer C; Zualo Wate P; Belton S; Prata N
    Reprod Health; 2018 Oct; 15(1):174. PubMed ID: 30326927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Knowledge and provision of misoprostol among pharmacy workers in Senegal: a cross sectional study.
    Reiss K; Footman K; Burke E; Diop N; Ndao R; Mane B; van Min M; Ngo TD
    BMC Pregnancy Childbirth; 2017 Jul; 17(1):211. PubMed ID: 28673342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Report of At-Scale Distribution of Chlorhexidine Digluconate 7.1% Gel for Newborn Cord Care to 36,404 Newborns in Sokoto State, Nigeria: Initial Lessons Learned.
    Orobaton N; Abegunde D; Shoretire K; Abdulazeez J; Fapohunda B; Lamiri G; Maishanu A; Ganiyu A; Ndifon E; Gwamzhi R; Osborne-Smith M
    PLoS One; 2015; 10(7):e0134040. PubMed ID: 26226017
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of misoprostol and chlorhexidine policy gains in Pakistan: the advocacy experience of Mercy Corps Pakistan.
    Sarwar Z; Cutherell A; Noor A; Naureen F; Norman J
    Health Res Policy Syst; 2015 Nov; 13 Suppl 1(Suppl 1):50. PubMed ID: 26792198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Facilitating women's access to misoprostol through community-based advocacy in Kenya and Tanzania.
    Coeytaux F; Hessini L; Ejano N; Obbuyi A; Oguttu M; Osur J; Shuken K
    Int J Gynaecol Obstet; 2014 Apr; 125(1):53-5. PubMed ID: 24447412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Community-level distribution of misoprostol to prevent postpartum hemorrhage at home births in northern Nigeria.
    Ejembi C; Shittu O; Moran M; Adiri F; Oguntunde O; Saadatu B; Aku-Akai L; Abdul MA; Ajayi V; Williams N; Prata N
    Afr J Reprod Health; 2014 Jun; 18(2):166-75. PubMed ID: 25022154
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trends in newborn umbilical cord care practices in Sokoto and Bauchi States of Nigeria: the where, who, how, what and the ubiquitous role of traditional birth attendants: a lot quality assurance sampling survey.
    Abegunde D; Orobaton N; Beal K; Bassi A; Bamidele M; Akomolafe T; Ohanyido F; Umar-Farouk O; Danladi S
    BMC Pregnancy Childbirth; 2017 Nov; 17(1):368. PubMed ID: 29121870
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Initiating a novel therapy in preventing postpartum hemorrhage in rural India: a joint collaboration between the United States and India.
    Kodkany BS; Derman RJ; Goudar SS; Geller SE; Edlavitch SA; Naik VA; Patel A; Bellad MB; Patted SS
    Int J Fertil Womens Med; 2004; 49(2):91-6. PubMed ID: 15188836
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Misoprostol for the prevention of post-partum haemorrhage in Mozambique: an analysis of the interface between human rights, maternal health and development.
    Hobday K; Zwi AB; Homer C; Kirkham R; Hulme J; Wate PZ; Prata N
    BMC Int Health Hum Rights; 2020 Apr; 20(1):9. PubMed ID: 32268892
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Community mobilization to reduce postpartum hemorrhage in home births in northern Nigeria.
    Prata N; Ejembi C; Fraser A; Shittu O; Minkler M
    Soc Sci Med; 2012 Apr; 74(8):1288-96. PubMed ID: 22377106
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Programmes for advance distribution of misoprostol to prevent post-partum haemorrhage: a rapid literature review of factors affecting implementation.
    Smith HJ; Colvin CJ; Richards E; Roberson J; Sharma G; Thapa K; Gülmezoglu AM
    Health Policy Plan; 2016 Feb; 31(1):102-13. PubMed ID: 25797470
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estimation of potential effects of improved community-based drug provision, to augment health-facility strengthening, on maternal mortality due to post-partum haemorrhage and sepsis in sub-Saharan Africa: an equity-effectiveness model.
    Pagel C; Lewycka S; Colbourn T; Mwansambo C; Meguid T; Chiudzu G; Utley M; Costello AM
    Lancet; 2009 Oct; 374(9699):1441-8. PubMed ID: 19783291
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of different models of access to misoprostol at the community level to improve maternal health outcomes in Ethiopia, Ghana, and Nigeria.
    Wells E; Coeytaux F; Azasi E; Danmusa S; Geressu T; McNally T; Potts J; Otive-Igbuzor E; Tibebu S
    Int J Gynaecol Obstet; 2016 Jun; 133(3):261-5. PubMed ID: 27158098
    [No Abstract]   [Full Text] [Related]  

  • 16. New hope: community-based misoprostol use to prevent postpartum haemorrhage.
    Prata N; Passano P; Bell S; Rowen T; Potts M
    Health Policy Plan; 2013 Jul; 28(4):339-46. PubMed ID: 22879523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interpretation of national policy regarding community-based use of misoprostol for postpartum hemorrhage prevention in Ethiopia: a tale of two regions.
    Spangler SA; Gobezayehu AG; Hailemariam TG; Sibley LM
    J Midwifery Womens Health; 2014 Jan; 59 Suppl 1():S83-90. PubMed ID: 24588920
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of sublingual misoprostol as first-line treatment for primary post-partum hemorrhage: results of a multicenter trial.
    Okonofua FE; Ogu RN; Akuse JT; Ujah IA; Galadanci HS; Fabamwo AO
    J Obstet Gynaecol Res; 2014 Mar; 40(3):718-22. PubMed ID: 24320203
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Women's self-reported experiences using misoprostol obtained from drug sellers: a prospective cohort study in Lagos State, Nigeria.
    Stillman M; Owolabi O; Fatusi AO; Akinyemi AI; Berry AL; Erinfolami TP; Olagunju OS; Väisänen H; Bankole A
    BMJ Open; 2020 May; 10(5):e034670. PubMed ID: 32376752
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A regional comparison of distribution strategies and women's awareness, receipt, and use of misoprostol to prevent postpartum hemorrhage in rural Amhara and Oromiya regions of Ethiopia.
    Sibley LM; Spangler SA; Barry D; Tesfaye S; Desta BF; Gobezayehu AG
    J Midwifery Womens Health; 2014 Jan; 59 Suppl 1():S73-82. PubMed ID: 24588919
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.